Home » Authors » Karen Young

Karen Young

Articles

ARTICLES

Hyseq Raises $15M Privately To Develop Proprietary Drugs

April 10, 2002

InterMune Licenses Rights To Phase II Candidate For Fibrosis

April 9, 2002

InterMune Inc. licensed worldwide rights to develop and commercialize pirfenidone for all fibrotic diseases, including renal, liver and pulmonary fibrosis a drug candidate that plays right into the company’s field of expertise. (BioWorld Today)

Mojave Presents First Human Data From Antigen Delivery System

April 9, 2002

Mojave Presents First Human Data From Antigen Delivery System

April 9, 2002

InterMune Licenses Rights To Phase II Candidate For Fibrosis

April 9, 2002

InterMune Inc. licensed worldwide rights to develop and commercialize pirfenidone for all fibrotic diseases, including renal, liver and pulmonary fibrosis a drug candidate that plays right into the company’s field of expertise. (BioWorld Today)

Allos Charting Oncology Path, In-Licenses Cancer Product

April 8, 2002

Allos Charting Oncology Path, In-Licenses Cancer Product

April 8, 2002

GenPhar Reveals Platform, Has Partnerships With Army, NIH

April 5, 2002

LifeTime Acquires Cancer Product From Dovetail For Equity Position

April 5, 2002

LifeTime Acquires Cancer Product From Dovetail For Equity Position

April 5, 2002

View All Articles by Karen Young

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...